Lava Therapeutics NVLVTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 21 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings, up 2 from Q2 2024. 4 opened new positions and 2 sold out. The largest holders were Redmile Group, LLC ($3.4M), Bruce & Co., Inc. ($1.3M) and Sphera Funds Management LTD. ($243K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $134K |
| Exits | 2 | $56K |
All 13F filers, Q2 2024 → Q3 2024: 191,562 shares bought and 341,547 shares sold, net −149,985 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Redmile Group, LLC | 0.20% | No change | 2,074,372 | $3.4M |
| Bruce & Co., Inc. | 0.37% | No change | 771,874 | $1.3M |
| Sphera Funds Management LTD. | 0.04% | Reduce -60.2% | 146,457 | $243K |
| Two Sigma Investments, LP | 0.00% | Reduce -8.6% | 102,766 | $171K |
| Pathway Financial Advisors LLC | 0.04% | Add +70.8% | 102,500 | $170K |
| Alpha Wave Global, LP | 0.05% | No change | 87,397 | $145K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $108K |
| Tang Capital Management LLC | 0.01% | Add +939.4% | 53,101 | $88K |
| Susquehanna International Group, LLP | 0.00% | New | 48,205 | $80K |
| Morgan Stanley | 0.00% | Add +133.3% | 36,400 | $60K |
| Two Sigma Advisers, LP | 0.00% | Reduce -15.1% | 26,900 | $45K |
| Virtu Financial LLC | 0.00% | New | 19,103 | $32K |
| Citadel Advisors | 0.00% | Reduce -74.3% | 17,013 | $28K |
| Walleye Capital LLC | 0.00% | Reduce -42.5% | 14,762 | $25K |
| Millennium Management | 0.00% | Reduce -54.5% | 12,063 | $20K |
| Engineers Gate Manager LP | 0.00% | New | 11,890 | $20K |
| Geode Capital Management, LLC | 0.00% | No change | 11,124 | $18K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 6,000 | $10K |
| UBS Group AG | 0.00% | New | 1,072 | $2K |
| Tsfg, LLC | 0.00% | No change | 400 | $1K |
| Simplex Trading, LLC | 0.00% | Reduce -77.4% | 51 | $0 |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.